Product Information
EVEROLIMUS 5 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $14.7708 per EA under NDC 51991082233. Its NADAC has been published 93 times since Sep 18, 2024.
Strength
5 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991082233
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
EVEROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA205426On Market Since
3/5/2021
Pharmacological Classes
Price Statistics
The NADAC for EVEROLIMUS 5 MG TABLET has been published 93 times since Sep 18, 2024, and over the history we have for it it has declined 27.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.7708 per EA |
|---|---|
| All-time high | $23.3127 (Jan 15, 2025) |
| All-time low | $14.7708 (Dec 17, 2025) |
| 52-week high | $17.5117 |
| 52-week low | $14.7708 |
| Median price | $17.5117 |
| Average price | $17.7520 |
| Largest weekly change | -15.7% (Dec 17, 2025) |
| Weeks tracked | 93 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EVEROLIMUS 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 5 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $14.7708 per EA (NDC 51991082233), effective Jun 24, 2026.
How has the price of EVEROLIMUS 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVEROLIMUS 5 MG TABLET has declined 27.5%. It has been tracked across 93 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for EVEROLIMUS 5 MG TABLET?
Since Sep 18, 2024, the NADAC for EVEROLIMUS 5 MG TABLET has ranged from a low of $14.7708 (Dec 17, 2025) to a high of $23.3127 (Jan 15, 2025), with a median of $17.5117 per EA.
Are there cheaper alternatives to EVEROLIMUS 5 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as EVEROLIMUS 5 MG TABLET, but none are currently priced below it.
Who manufactures EVEROLIMUS 5 MG TABLET?
EVEROLIMUS 5 MG TABLET (NDC 51991082233) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification